• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环基质金属蛋白酶-9 水平与腹主动脉病变:来自达拉斯心脏研究。

Circulating levels of matrix metalloproteinase-9 and abdominal aortic pathology: from the Dallas Heart Study.

机构信息

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA.

出版信息

Vasc Med. 2011 Oct;16(5):339-45. doi: 10.1177/1358863X11422110.

DOI:10.1177/1358863X11422110
PMID:22002999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3523319/
Abstract

Prior reports have associated increased circulating levels of matrix metalloproteinase-9 (MMP-9), an endopeptidase active in the extracellular matrix, with the formation and rupture of aortic aneurysms, raising the possibility that MMP-9 may be a useful diagnostic or therapeutic target for aortic pathology. However, associations between MMP-9 and pathological abdominal aortic phenotypes in the general population have not been reported. In the Dallas Heart Study, a population-based sample of Dallas County residents (n = 2304), we measured MMP-9 and performed magnetic resonance imaging (MRI) of the abdominal aorta, measuring aortic compliance, plaque, wall thickness and luminal diameter. After adjustment for traditional cardiac risk factors and body size, higher MMP-9 quartiles were independently associated with higher aortic wall thickness and larger luminal diameter (p < 0.0001 for each), but not abdominal aortic plaque (p = 0.08), coronary artery calcium (p = 0.20) or the aortic luminal diameter/aortic wall thickness ratio (p = 0.37), supporting the hypothesis that therapies targeting MMP-9 may affect the abdominal aortic wall and modify aortic pathology.

摘要

先前的报告表明,基质金属蛋白酶-9(MMP-9)的循环水平升高与主动脉瘤的形成和破裂有关,MMP-9 是细胞外基质中具有活性的内肽酶,这提示 MMP-9 可能是一种有用的主动脉病变的诊断或治疗靶点。然而,在一般人群中,MMP-9 与病理性腹主动脉表型之间的关系尚未有报道。在达拉斯心脏研究中,我们对达拉斯县居民的一个基于人群的样本(n = 2304)进行了 MMP-9 测量和腹部主动脉磁共振成像(MRI)检查,测量了主动脉顺应性、斑块、壁厚度和管腔直径。在调整传统的心脏危险因素和体型后,较高的 MMP-9 四分位数与较高的主动脉壁厚度和较大的管腔直径独立相关(每个四分位数的 p < 0.0001),但与腹主动脉斑块(p = 0.08)、冠状动脉钙(p = 0.20)或主动脉管腔直径/主动脉壁厚度比值(p = 0.37)无关,这支持了靶向 MMP-9 的治疗可能影响腹主动脉壁并改变主动脉病变的假说。

相似文献

1
Circulating levels of matrix metalloproteinase-9 and abdominal aortic pathology: from the Dallas Heart Study.循环基质金属蛋白酶-9 水平与腹主动脉病变:来自达拉斯心脏研究。
Vasc Med. 2011 Oct;16(5):339-45. doi: 10.1177/1358863X11422110.
2
Systemic dilation diathesis in patients with abdominal aortic aneurysms: a role for matrix metalloproteinase-9?腹主动脉瘤患者的全身扩张素质:基质金属蛋白酶-9的作用?
Eur J Vasc Endovasc Surg. 2005 Apr;29(4):371-7. doi: 10.1016/j.ejvs.2005.01.009.
3
Race-specific associations of myeloperoxidase with atherosclerosis in a population-based sample: the Dallas Heart Study.基于人群样本的髓过氧化物酶与动脉粥样硬化的种族特异性关联:达拉斯心脏研究。
Atherosclerosis. 2011 Dec;219(2):833-8. doi: 10.1016/j.atherosclerosis.2011.08.029. Epub 2011 Aug 22.
4
Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity.腹主动脉瘤管腔内血栓与管壁完整性破坏有关。
J Vasc Surg. 2013 Jan;57(1):77-83. doi: 10.1016/j.jvs.2012.07.003. Epub 2012 Nov 3.
5
Prevention of abdominal aortic aneurysm progression by targeted inhibition of matrix metalloproteinase activity with batimastat-loaded nanoparticles.通过载有batimastat的纳米颗粒靶向抑制基质金属蛋白酶活性来预防腹主动脉瘤进展。
Circ Res. 2015 Nov 6;117(11):e80-9. doi: 10.1161/CIRCRESAHA.115.307207. Epub 2015 Oct 6.
6
Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture.腹主动脉瘤中基质金属蛋白酶-2和-9的活性。与大小和破裂的关系。
Eur J Vasc Endovasc Surg. 2000 Nov;20(5):457-61. doi: 10.1053/ejvs.2000.1211.
7
Relationship between inflammation and progression of an abdominal aortic aneurysm in a rabbit model based on 18F-FDG PET/CT imaging.基于18F-FDG PET/CT成像的兔腹主动脉瘤模型中炎症与腹主动脉瘤进展的关系
Vascular. 2018 Dec;26(6):571-580. doi: 10.1177/1708538118768126. Epub 2018 Apr 20.
8
Background differences in baseline and stimulated MMP levels influence abdominal aortic aneurysm susceptibility.基线和刺激后的基质金属蛋白酶水平的背景差异会影响腹主动脉瘤易感性。
Atherosclerosis. 2015 Dec;243(2):621-9. doi: 10.1016/j.atherosclerosis.2015.10.006. Epub 2015 Oct 8.
9
Size matters: the relationship between MMP-9 expression and aortic diameter.尺寸很重要:基质金属蛋白酶-9表达与主动脉直径之间的关系。
Circulation. 1997 Oct 7;96(7):2228-32. doi: 10.1161/01.cir.96.7.2228.
10
Clearance of matrix metalloproteinase-9 is dependent on low-density lipoprotein receptor-related protein-1 expression downregulated by microRNA-205 in human abdominal aortic aneurysm.基质金属蛋白酶-9的清除依赖于人类腹主动脉瘤中被微小RNA-205下调的低密度脂蛋白受体相关蛋白-1的表达。
J Vasc Surg. 2017 Feb;65(2):509-520. doi: 10.1016/j.jvs.2015.10.065. Epub 2016 Jan 9.

引用本文的文献

1
The contribution of matrix metalloproteinases and their inhibitors to the development, progression, and rupture of abdominal aortic aneurysms.基质金属蛋白酶及其抑制剂在腹主动脉瘤的发生、发展和破裂中的作用。
Front Cardiovasc Med. 2023 Sep 19;10:1248561. doi: 10.3389/fcvm.2023.1248561. eCollection 2023.
2
The Role of Immune Mechanisms in Abdominal Aortic Aneurysm: Could It be a Promising Therapeutic Strategy?免疫机制在腹主动脉瘤中的作用:它会是一种有前景的治疗策略吗?
Acta Cardiol Sin. 2023 Sep;39(5):675-686. doi: 10.6515/ACS.202309_39(5).20230531A.
3
Role of Extracellular Matrix and Inflammation in Abdominal Aortic Aneurysm.细胞外基质和炎症在腹主动脉瘤中的作用。
Int J Mol Sci. 2022 Sep 21;23(19):11078. doi: 10.3390/ijms231911078.
4
Crucial role of hematopoietic V617F in the development of aortic aneurysms.造血细胞V617F在主动脉瘤发展中的关键作用。
Haematologica. 2021 Jul 1;106(7):1910-1922. doi: 10.3324/haematol.2020.264085.
5
Serum matrix metalloproteinase-9 is a valuable biomarker for identification of abdominal and thoracic aortic aneurysm: a case-control study.血清基质金属蛋白酶-9是用于识别腹主动脉瘤和胸主动脉瘤的一种有价值的生物标志物:一项病例对照研究。
BMC Cardiovasc Disord. 2018 Oct 29;18(1):202. doi: 10.1186/s12872-018-0931-0.
6
Large artery stiffness is associated with salt intake in young healthy black but not white adults: the African-PREDICT study.大动脉僵硬与年轻健康的黑人群体(而非白人群体)的盐摄入量有关:非洲 PREDICT 研究。
Eur J Nutr. 2018 Oct;57(7):2649-2656. doi: 10.1007/s00394-018-1791-1. Epub 2018 Jul 21.
7
Ruptured abdominal aortic aneurysm-epidemiology, predisposing factors, and biology.腹主动脉瘤破裂——流行病学、诱发因素及生物学特性
Langenbecks Arch Surg. 2016 May;401(3):275-88. doi: 10.1007/s00423-016-1401-8. Epub 2016 Mar 21.
8
Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia.严重肢体缺血患者的基线血小板活化与反应性
PLoS One. 2015 Jul 6;10(7):e0131356. doi: 10.1371/journal.pone.0131356. eCollection 2015.
9
Correlation of circulating MMP-9 with white blood cell count in humans: effect of smoking.循环 MMP-9 与白细胞计数的相关性:吸烟的影响。
PLoS One. 2013 Jun 25;8(6):e66277. doi: 10.1371/journal.pone.0066277. Print 2013.
10
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.病例-队列研究中血浆基质金属蛋白酶-9与新发心房颤动风险的新关联:社区动脉粥样硬化风险研究。
PLoS One. 2013;8(3):e59052. doi: 10.1371/journal.pone.0059052. Epub 2013 Mar 15.

本文引用的文献

1
Downregulation of remodelling enzymatic activity induced by an angiotensin-converting enzyme inhibitor (perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a rat model.血管紧张素转换酶抑制剂(培哚普利)下调重塑酶活性可减少大鼠实验性腹主动脉瘤的退行性变。
Eur J Vasc Endovasc Surg. 2011 Apr;41(4):474-80. doi: 10.1016/j.ejvs.2010.12.007. Epub 2011 Jan 20.
2
The protein kinase C cascade regulates recruitment of matrix metalloprotease 9 to podosomes and its release and activation.蛋白激酶 C 级联反应调节基质金属蛋白酶 9 募集到足突并将其释放和激活。
Mol Cell Biol. 2010 Dec;30(23):5545-61. doi: 10.1128/MCB.00382-10. Epub 2010 Oct 11.
3
Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals.对超过 300 万个体队列的腹主动脉瘤风险因素分析。
J Vasc Surg. 2010 Sep;52(3):539-48. doi: 10.1016/j.jvs.2010.05.090. Epub 2010 Jul 13.
4
Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence.不同民族间基质金属蛋白酶遗传多态性的分布差异与疾病患病率的民族差异一致。
DNA Cell Biol. 2010 Nov;29(11):649-55. doi: 10.1089/dna.2010.1056. Epub 2010 Jun 30.
5
The aorta wall of patients presenting to the emergency department with acute myocardial infarction by cardiac magnetic resonance.经心脏磁共振检查,在急诊科就诊的急性心肌梗死患者的主动脉壁。
Atherosclerosis. 2010 Sep;212(1):166-70. doi: 10.1016/j.atherosclerosis.2010.05.002. Epub 2010 May 12.
6
Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromsø study.腹主动脉瘤中的动脉粥样硬化:因果事件还是平行发生的过程?特罗姆瑟研究。
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1263-8. doi: 10.1161/ATVBAHA.110.203588. Epub 2010 Apr 1.
7
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.他汀类药物抑制人内皮细胞中环氧化酶-2 和基质金属蛋白酶-9:可能有助于斑块稳定的抗血管生成作用。
Cardiovasc Res. 2010 May 1;86(2):311-20. doi: 10.1093/cvr/cvp375. Epub 2009 Nov 27.
8
Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm.抗晚期糖基化终末产物受体疗法作为腹主动脉瘤的新型治疗方法。
Ann Surg. 2009 Sep;250(3):416-23. doi: 10.1097/SLA.0b013e3181b41a18.
9
Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-analysis.循环基质金属蛋白酶-9浓度与腹主动脉瘤的存在:一项荟萃分析。
Interact Cardiovasc Thorac Surg. 2009 Sep;9(3):437-40. doi: 10.1510/icvts.2009.208835. Epub 2009 Jun 12.
10
Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment.原发性高血压患者血清基质金属蛋白酶-9和金属蛋白酶组织抑制因子-1水平及降压治疗的影响
Eur J Intern Med. 2009 Jul;20(4):369-72. doi: 10.1016/j.ejim.2008.10.003. Epub 2008 Nov 28.